UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012035
Receipt number R000014067
Scientific Title Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle Biopsy
Date of disclosure of the study information 2013/10/15
Last modified on 2018/04/23 15:29:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle Biopsy

Acronym

CNB for Breast Cancer Acquired cCR with NAC

Scientific Title

Feasibility Study to Assess Diagnostic Accuracy of Pathological Complete Response with Core Needle Biopsy

Scientific Title:Acronym

CNB for Breast Cancer Acquired cCR with NAC

Region

Japan


Condition

Condition

Invasive Breast Cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess feasibility of diagnostic accuracy of pathological complete response (pCR) with core needle biopsy(CNB) for breast cancer patient who acquired clinical complete response (cCR) with neoadjuvant chemothrapy. If pCR is diagnosed with CNB correctly, we have opportunity to omit surgical procedure for resection.

Basic objectives2

Others

Basic objectives -Others

Feasibility study to assess diagnostic accuracy of pathological complete response with core needle biopsy.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Accuracy of pCR with CNB

Key secondary outcomes

Accuracy of pCR with imaging study.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Core needle biopsy is performed just before resection of the primary lesion under general anesthegia for the resection procedure.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Female

Key inclusion criteria

1) Woman age of 20 to 75 years old at registration.
2) Invasive breast cancer proven by core biopsy.
3) Negative for estrogen receptor immunohistochemically.
4) No prior therapy including radiation, endocrine therapy or immunotherapy except for neoadjuvant chemotherapy for existing breast cancer.
5) Expected complete response for invasive cancer by neoadjuvant chemotherapy with imaging study.
6) Informed consent must be obtained before patient registration.

Key exclusion criteria

1) Male gender
2) Judged to be inadequate by the doctor.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazutaka Narui

Organization

Yokohama City University Medical Center

Division name

Department of Breast and Thyroid Surgery

Zip code


Address

4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan

TEL

045-261-5656

Email

nr1@gc5.so-net.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazutaka Narui

Organization

Yokohama City University Medical Center

Division name

Department of Breast and Thyroid Surgery

Zip code


Address

4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan

TEL

045-261-5656

Homepage URL


Email

nr1@gc5.so-net.ne.jp


Sponsor or person

Institute

Yokohama City University Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属市民総合医療センター(神奈川県)
東海大学付属病院(神奈川県)
聖マリアンナ医科大学病院(神奈川県)
聖マリアンナ医科大学ブレスト&イメージング(神奈川県)
北里大学病院(神奈川県)
神奈川県立がんセンター(神奈川県)
大船中央病院(神奈川県)
横浜労災病院(神奈川県)
湘南記念病院(神奈川県)
横浜市立みなと赤十字病院(神奈川県)
横浜旭中央総合病院(神奈川県)
東海大学付属八王子病院(神奈川県)
横浜市立大学附属病院(神奈川県)
弘前市立病院(青森県)
東京医科大学八王子医療センター(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 04 Day

Date of IRB


Anticipated trial start date

2013 Year 10 Month 15 Day

Last follow-up date

2015 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 10 Month 15 Day

Last modified on

2018 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014067


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name